These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11677394)

  • 1. [Multiple sclerosis: spontaneous course, natural history].
    Vukusic S; Moreau T; Bouhour F; Adeleine P; Confavreux C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):753-6. PubMed ID: 11677394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of follow-up and disease course].
    Roullet E
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1121-3. PubMed ID: 11787343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New immunomodulator for multiple sclerosis patients. 30% fewer relapse rates].
    MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta-interferon clinical trials using MRI in patients with multiple sclerosis].
    Lebrun C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):761-7. PubMed ID: 11677396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized crossover study of bee sting therapy for multiple sclerosis.
    Wesselius T; Heersema DJ; Mostert JP; Heerings M; Admiraal-Behloul F; Talebian A; van Buchem MA; De Keyser J
    Neurology; 2005 Dec; 65(11):1764-8. PubMed ID: 16221950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of progressive multiple sclerosis in Brazilian patients.
    Vasconcelos CC; Miranda-Santos CM; Alvarenga RM
    Neuroepidemiology; 2006; 26(4):233-9. PubMed ID: 16707908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
    Giovannoni G
    Mult Scler; 2011 Mar; 17(3):259-61. PubMed ID: 21362756
    [No Abstract]   [Full Text] [Related]  

  • 10. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
    Motl RW; Snook EM; Wynn DR; Vollmer T
    J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis.
    Boggild M; Ford H
    Clin Evid; 2002 Jun; (7):1195-207. PubMed ID: 12230737
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple sclerosis. Therapeutic nihilism is the wrong approach here].
    Voltz R; Goebels N; Jarius S; Hohlfeld R
    MMW Fortschr Med; 2002 May; Suppl 2():52-7. PubMed ID: 12070851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic criteria of multiple sclerosis with reference to different clinical forms].
    Dimitri D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):914-28. PubMed ID: 11787356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis.
    Hawker K; Frohman E
    Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of MRI in the diagnosis and the natural course of multiple sclerosis].
    Tourbah A; Lyon-Caen O
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):757-60. PubMed ID: 11677395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of progressive forms of multiple sclerosis].
    Edan G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1008-13. PubMed ID: 11787331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.